Application of HPLC for the determination of racemic fluoxetine and norfluoxetine in human plasma

Chemia Analityczna

Volumn 47, Issue 2, 2002, Pages 229-240

  Misztal, Genowefa ^a   Skibiński, Robert ^a   Olajossy, Marcin ^a   Paw, Beata ^a   Przyborowski, Lech ^a   Hopkala H ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Assay; Fluoxetine; HPLC; Norfluoxetine; Plasma; Solid phase extraction

Indexed keywords

ACETONITRILE; FLUOXETINE; FLUVOXAMINE; METHANOL; NORFLUOXETINE; PHOSPHATE; TRIETHYLAMINE;

ACCURACY; ADULT; ANALYTIC METHOD; ARTICLE; CALIBRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG EFFECT; DRUG PURIFICATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MENTAL HEALTH; PH; VALIDATION PROCESS;

EID: 0036000867     PISSN: 00092223     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Lemberger L., Rowe H., Carmichael M.S., Oldham S., Horng J.S., Bymaster F. and Wong D., Clin. Pharmacol. Ther., 23, 421 (1978).
2. Stark P., Fuller R. W. and Wong D.T., J. Clin. Psychiatry, 46, 7 (1985).
3. Stark P. and Hardison C.D., J. Clin. Psychiatry, 46, 53 (1985).
4. Hamilton M. and Neurol J., Neurosurg. Psychiatry, 23, 56 (1960).
5. Wong S.H., Deltafera S.S., Fernandes R. and Kranzler H., J. Chromatogr., 499, 601 (1990).
6. Vanderberghe H. and Bassoo E., Recent Dev. Ther. Drug, Monit. Clin. Toxicol., 475 (1992).
7. Holladay J.W., Dewey M.J. and Yoo S.D., J. Chromatogr., B., 704, 259 (1997).
8. Gennaro M.C., Abrigo C., Angelino S., Albert H., Bogetto F., Maina G., Prolo P. and Ravizza L., J. Liq. Chromatogr. Relat. Technol., 20, 3017 (1997).
9. McIntyre I.M., King V. Ch., Skafidis S. and Drummer O.H., J. Chromatogr. B., 621, 215 (1993).
10. El-Yazigi A. and Raines D.A., Ther. Drug Monit., 15, 305 (1993).
11. Misztal G. and Hopkala H., Pharmazie, 52, 854 (1997).
12. Alvarez J.C., Bothua D., Collignon I., Advenier Ch. and Spreux-Varoguaux O., J. Chromatogr. B, 707, 175 (1998).
13. Thomare P., Wang K., Van der Meersch-Mongeot V. and Diquet B., J. Chromatogr., 583, 217 (1992).
14. Kelly M.W., Perry P.J., Holdstand S.G. and Garrey M.J., Ther. Drug Monit., 11, 165 (1989).
15. Nichols J.H., Charlson J.R. and Lawson G.M., Clin. Chem. (Washington, D.C.), 40, 1312 (1994).
16. Gupta R.N. and Steiner M., J. Liq. Chromatogr., 13, 3785 (1991).
17. Suckow R.F., Zhang M.F. and Cooper T.B., Clin. Chem. (Winston-Salem, N.C.), 38, 1756 (1992).
18. Raggi M.A., Maudridi R., Casamenti G., Volterra V., Desiderio C. and Fanali S., Chromatographia, 50, 423 (1999).
19. Aymard G., Livi P., Pham Y.T. and Diquiet B., J. Chromatogr. B, 700, 183 (1997).
20. Kelly M.W., Perry P.J., Holstad S.G. and Garvey M.J., Ther. Drug Monit., 11, 165 (1989).
21. Jr Beasley C.M., Bosomworth J.C. and Wernicke J.F., Psychopharmacol. Bull., 26, 18 (1990).
22. Norman T.R., Gupta R.K., Burrows G.D. and Parker G., Int. Clin. Pharmacol., 8, 25 (1993).
23. Montgomery S.A., Baldwin D., Shah A., Green M., Fineberg M. and Montgamery D., Clin. Neuropharmacol., 13 (Suppl. 1) S71 (1990)
24. Fichtner C.G., Jobe T.H. and Braun B.G., J. Clin. Psychiatry, 55, 36 (1992).
25. Cain J.W., J. Clin. Psychiatry, 53, 127 (1992).
26. Altamura A.C., Moro A.R. and Percundani M., Clin. Pharmacokinet., 26, 201 (1994).
27. International Statistical Classification of Diseases and Health Related Problems, 10th Revision Edn, World Health Organization, Geneva 1997.